antiangiogenic


Also found in: Medical, Wikipedia.
Related to antiangiogenic: Antiangiogenic Therapy

an·ti·an·gi·o·gen·ic

 (ăn′tē-ăn′jē-ō-jĕn′ĭk, ăn′tī-)
adj.
Of or relating to a naturally occurring substance, drug, or other compound that can destroy or interfere with the fine network of blood vessels needed by tumors to grow and metastasize.
Mentioned in ?
References in periodicals archive ?
The interim study data show that ME-344 was generally well-tolerated and, consistent with previous preclinical data, demonstrate the potential to reverse resistance to antiangiogenic therapy.
The relatively new antiangiogenic drug injection therapy slows the progression of vision loss by stopping the abnormal blood vessels from growing and helping to control the leakage.
It also added that ramucirumab is the first antiangiogenic agent to extend progression-free survival in any urothelial cancer phase three study.
For this relevant unmet medical need, many laboratories and pharmaceutical companies have focused on developing new biomarkers and new drugs to fight anti-angiogenic resistance, but up to date, there is no proven established biomarker or method to predict which patients tumor is resistant to antiangiogenic therapies and which drug is capable of blocking this resistance to therapy.
In this study, the aims are to determine of antioxidants and antiangiogenic properties, and phytoconstituents quantitative of aqueous and methanol extracts of S.
Because angiofibromas are known to contain a highly vascular component expressing angiogenic factors such as VEGF [vascular endothelial growth factor], it is likely the patient's right cheek improved due to the antiangiogenic and proapoptotic effects of the topically administered beta-blocker," wrote Dr.
PE patients were found to have high concentrations of antiangiogenic factors [e.
Available treatments include the splenectomy to antiangiogenic therapy.
3) Nevertheless, both intrinsic and acquired resistance to antiangiogenic drugs are emerging as clinically relevant issues.
Our study firstly provides the evidence that RA has high antiangiogenic potency and explores its molecular basis, demonstrating that RA is a potential agent or lead candidate for antiangiogenic cancer therapy.
The research centres on the role in the body of the signal protein, vascular endothelial growth factor (VEGF) which comes in two formspro angiogenic, which encourages the growth of blood vessels, and antiangiogenic, which inhibits vascular growth.
VEGF-xxx isoforms are pro-angiogenic and VEGF-xxxb are antiangiogenic and as it is known, xxx demonstrates the amino acid number of mature proteins.